Gilead Sciences | Revenu Net

Prix De L'Action
152.50
Variation Quotidienne
3.13 2.10%
Mensuellement
22.64%
Annuel
58.79%
Q1 Prévisions
147.82




Revenu Net Changement Date
AbbVie USD 1.82B 1.63B 2025-12
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
ALKERMES USD 82.76M 4.34M 2025-09
Alnylam Pharmaceuticals USD 251.08M 317.36M 2025-09
Amgen USD 1.33B 1.88B 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 3.05B 1.09B 2025-09
GlaxoSmithKline GBP 636M 1.38B 2025-12
Glaxosmithkline GBP 2.71B 1.27B 2025-09
Incyte USD 424.17M 19.17M 2025-09
J&J USD 5.12B 36M 2025-12
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD 15.9M 80.75M 2025-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
United Therapeutics USD 338.7M 29.2M 2025-09
Vertex Pharmaceuticals USD 1.08B 50M 2025-09


Gilead Sciences Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.